Efficacy News and Research

RSS
VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Study reveals cost-effective benefits of treating depression in low-income countries

Study reveals cost-effective benefits of treating depression in low-income countries

Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients

Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients

Drug repurposing offers hope for SYNGAP1 patients

Drug repurposing offers hope for SYNGAP1 patients

New approach for cervical cancer vaccines based on microsphere-encapsulated peptides

New approach for cervical cancer vaccines based on microsphere-encapsulated peptides

Boosting Treg cells shows promise in preventing recurrent pregnancy loss

Boosting Treg cells shows promise in preventing recurrent pregnancy loss

Scientists discover novel compound to combat age-related blindness

Scientists discover novel compound to combat age-related blindness

Study highlights importance of RSV vaccination for high-risk populations

Study highlights importance of RSV vaccination for high-risk populations

Novel class of encrypted peptides offers hope against drug-resistant bacteria

Novel class of encrypted peptides offers hope against drug-resistant bacteria

Study finds pistachios might help guard against vision loss

Study finds pistachios might help guard against vision loss

Ozempic effective for patients with chronic kidney damage

Ozempic effective for patients with chronic kidney damage

Expanded access to weight-loss drugs could save thousands of lives

Expanded access to weight-loss drugs could save thousands of lives

Phase 3 trial assesses clazakizumab in kidney transplant recipients with caAMR

Phase 3 trial assesses clazakizumab in kidney transplant recipients with caAMR

Bioactive peptides from Chlorella vulgaris for therapeutic applications

Bioactive peptides from Chlorella vulgaris for therapeutic applications

New trial shows felzartamab reduces proteinuria in IgA nephropathy patients

New trial shows felzartamab reduces proteinuria in IgA nephropathy patients

New analysis confirms canagliflozin's cardiovascular and kidney benefits in older adults

New analysis confirms canagliflozin's cardiovascular and kidney benefits in older adults

MHRA greenlights donanemab for early stage Alzheimer’s disease

MHRA greenlights donanemab for early stage Alzheimer’s disease

New research trial aims to address a disabling post-stroke condition

New research trial aims to address a disabling post-stroke condition

Extracellular vesicles play key role in cancer drug resistance

Extracellular vesicles play key role in cancer drug resistance

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.